Pharmaceutical Industry Updates: Product Applications, Shareholder Meetings, and Financial Performance
①Celltrion applies for European product approval for CT-P47 (Roactemra biosimilar) = Celltrion announced on the 13th that it has applied for European product approval for CT-P47 (Roactemra biosimilar). The indications are △ rheumatoid arthritis △ giant cell arteritis △ systemic type juvenile arthritis △ polyarticular type juvenile arthritis △ cytokine release syndrome △ coronavirus -19 […]
